142 related articles for article (PubMed ID: 16440325)
1. RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells.
Cesarone G; Garofalo C; Abrams MT; Igoucheva O; Alexeev V; Yoon K; Surmacz E; Wickstrom E
J Cell Biochem; 2006 May; 98(2):440-50. PubMed ID: 16440325
[TBL] [Abstract][Full Text] [Related]
2. Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1.
Cesarone G; Edupuganti OP; Chen CP; Wickstrom E
Bioconjug Chem; 2007; 18(6):1831-40. PubMed ID: 17922544
[TBL] [Abstract][Full Text] [Related]
3. An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer.
Mamay CL; Mingo-Sion AM; Wolf DM; Molina MD; Van Den Berg CL
Oncogene; 2003 Jan; 22(4):602-14. PubMed ID: 12555073
[TBL] [Abstract][Full Text] [Related]
4. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
[TBL] [Abstract][Full Text] [Related]
5. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells.
Morelli C; Garofalo C; Bartucci M; Surmacz E
Oncogene; 2003 Jun; 22(26):4007-16. PubMed ID: 12821935
[TBL] [Abstract][Full Text] [Related]
7. Role of IRS-1 signaling in insulin-induced modulation of estrogen receptors in breast cancer cells.
Andò S; Panno ML; Salerno M; Sisci D; Mauro L; Lanzino M; Surmacz E
Biochem Biophys Res Commun; 1998 Dec; 253(2):315-9. PubMed ID: 9878535
[TBL] [Abstract][Full Text] [Related]
8. IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells.
Jackson JG; Yee D
Growth Horm IGF Res; 1999 Oct; 9(5):280-9. PubMed ID: 10543935
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.
del Rincón SV; Rousseau C; Samanta R; Miller WH
Oncogene; 2003 May; 22(22):3353-60. PubMed ID: 12776186
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
11. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
13. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
14. Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
Thomas NB; Hutcheson IR; Campbell L; Gee J; Taylor KM; Nicholson RI; Gumbleton M
Breast Cancer Res Treat; 2010 Feb; 119(3):575-91. PubMed ID: 19288272
[TBL] [Abstract][Full Text] [Related]
15. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression.
Mukohara T; Shimada H; Ogasawara N; Wanikawa R; Shimomura M; Nakatsura T; Ishii G; Park JO; Jänne PA; Saijo N; Minami H
Cancer Lett; 2009 Sep; 282(1):14-24. PubMed ID: 19345478
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A
Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144
[TBL] [Abstract][Full Text] [Related]
18. Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells.
Mauro L; Salerno M; Panno ML; Bellizzi D; Sisci D; Miglietta A; Surmacz E; Andò S
Biochem Biophys Res Commun; 2001 Nov; 288(3):685-9. PubMed ID: 11676497
[TBL] [Abstract][Full Text] [Related]
19. RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines.
Cuevas EP; Escribano O; Monserrat J; Martínez-Botas J; Sánchez MG; Chiloeches A; Hernández-Breijo B; Sánchez-Alonso V; Román ID; Fernández-Moreno MD; Guijarro LG
J Cell Biochem; 2009 Dec; 108(6):1292-301. PubMed ID: 19795387
[TBL] [Abstract][Full Text] [Related]
20. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
